Document Detail


Follow-up of preterm infants treated with dexamethasone for chronic lung disease.
MedLine Citation:
PMID:  8506835     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To study the outcome of prolonged treatment with dexamethasone sodium phosphate in preterm infants who depend on assisted ventilation. DESIGN: Longitudinal follow-up using historic controls. SETTING: Regional intensive care nursery. PARTICIPANTS: Sixty-one very-low-birth-weight infants treated with a 42-day course of dexamethasone and 61 historic controls matched for birth weight, gestational age, race, and sex. All 122 subjects required assisted ventilation for at least 15 days. INTERVENTION: Infants were given dexamethasone sodium phosphate at a dose of 0.5 mg/kg per day. The dose was then tapered over 42 days. MEASUREMENTS/MAIN RESULTS: Infants treated with dexamethasone received assisted ventilation for a median of 33 days; controls, a median of 47 days (P < .05). One hundred infants survived; 94 were examined at age 1 year. The two groups were similar with respect to the proportions hospitalized for respiratory infection in the first year of life and the proportions with weight, length, and head circumference below the fifth percentile. Rates of cerebral palsy were also similar between the two groups, as were median Bayley Mental and Psychomotor developmental index scores. CONCLUSIONS: Dexamethasone treatment was associated with fewer days of assisted ventilation, but not with improved outcome at age 1 year. More assessment should be made of dexamethasone's effect on long-term outcome before dexamethasone becomes widely used in preterm infants who depend on assisted ventilation.
Authors:
T M O'Shea; J M Kothadia; K L Klinepeter; D J Goldstein; B Jackson; R G Dillard
Related Documents :
23082555 - Severe perinatal dengue hemorrhagic fever in a low birth weight infant.
24477335 - Manganese concentrations in maternal-infant blood and birth weight.
24618495 - Aggressive posterior retinopathy of prematurity in infants ≥1500 g birth weight.
23020135 - Early growth velocities and weight gain plasticity improve linear growth in peruvian in...
19369375 - Oral supplementation with probiotics in very-low-birth-weight preterm infants: a random...
14993525 - Summary statistics of neonatal intensive care unit network neurobehavioral scale scores...
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American journal of diseases of children (1960)     Volume:  147     ISSN:  0002-922X     ISO Abbreviation:  Am. J. Dis. Child.     Publication Date:  1993 Jun 
Date Detail:
Created Date:  1993-07-07     Completed Date:  1993-07-07     Revised Date:  2010-03-24    
Medline Journal Info:
Nlm Unique ID:  0370471     Medline TA:  Am J Dis Child     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  658-61     Citation Subset:  AIM; IM    
Affiliation:
Department of Pediatrics, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Chronic Disease
Combined Modality Therapy
Dexamethasone / analogs & derivatives*,  therapeutic use
Female
Follow-Up Studies
Humans
Infant
Infant, Low Birth Weight*
Infant, Newborn
Infant, Premature, Diseases / therapy*
Longitudinal Studies
Lung Diseases / therapy*
Male
Respiration, Artificial*
Time Factors
Treatment Outcome
Chemical
Reg. No./Substance:
312-93-6/dexamethasone 21-phosphate; 50-02-2/Dexamethasone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of childre...
Next Document:  Prolonged pH monitoring is of limited usefulness for gastroesophageal reflux.